Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
American Journal of Clinical Pathology|July 31, 2016
The Crossmatch/Issue Ratio:  Use of a Novel Quality Indicator and Results of an International Survey on RBC Crossmatching and Issuing PracticesMark H Yazer, Ramir Alcantara, Pouneh Beizai, et al.
The Journal of Trauma and Acute Care Surgery|July 5, 2021
A pilot study of stored low titer group O whole blood + component therapy versus component therapy only for civilian trauma patientsAnaar E Siletz, Kevin J Blair, Richelle J Cooper, et al.
Lancet (London, England)|April 17, 2016
Transfusion reactions: prevention, diagnosis, and treatmentMeghan Delaney, Silvano Wendel, Rachel S Bercovitz, et al.
Transfusion|April 14, 2019
Comparison of titer results obtained using immediate spin one-dilution techniques to a reference methodMark H Yazer, Nancy M Dunbar, Carolina Bonet Bub, et al.
Transfusion|June 24, 2022
Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative studyJansen N Seheult, Jeannie Callum, Meghan Delaney, et al.
Transfusion|February 23, 2023
Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative studyWen Lu, Alyssa Ziman, Matthew T S Yan, et al.
Transfusion|July 6, 2021
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance studyJoseph H Cho, Srijana Rajbhandary, Nancy L van Buren, et al.
Transfusion|March 27, 2023
Transfusion of ABO-group identical red blood cells following uncrossmatched transfusion does not lead to higher mortality in civilian trauma patientsMark H Yazer, Nancy M Dunbar, John R Hess, et al.
Transplantation and Cellular Therapy|September 25, 2025
Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplantation: The BEST Collaborative StudyValery Kogler, Monica B Pagano, Magali J Fontaine, et al.
Transfusion|February 7, 2022
Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatmentAnil Bagri, Rafael R de Assis, Cheng-Ting Tsai, et al.
Pageof 8